We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Results: 5

1.
Figure 5

Figure 5. From: The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions.

The extended BOADICEA transition model for female patients.

A C Antoniou, et al. Br J Cancer. 2008 April 22;98(8):1457-1466.
2.
Figure 2

Figure 2. From: The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions.

Average cumulative ovarian cancer risks for BRCA1 mutation carriers by birth cohort assumed in BOADICEA.

A C Antoniou, et al. Br J Cancer. 2008 April 22;98(8):1457-1466.
3.
Figure 4

Figure 4. From: The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions.

Average cumulative ovarian cancer risks for BRCA2 mutation carriers by birth cohort assumed in BOADICEA.

A C Antoniou, et al. Br J Cancer. 2008 April 22;98(8):1457-1466.
4.
Figure 3

Figure 3. From: The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions.

Average cumulative breast cancer risks for BRCA2 mutation carriers by birth cohort assumed in BOADICEA.

A C Antoniou, et al. Br J Cancer. 2008 April 22;98(8):1457-1466.
5.
Figure 1

Figure 1. From: The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions.

Average cumulative breast cancer risks for BRCA1 mutation carriers by birth cohort assumed in BOADICEA.

A C Antoniou, et al. Br J Cancer. 2008 April 22;98(8):1457-1466.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk